Active	Status	Sponsor type	Region	Phase	Filter
7 Active 26 Inactive 33 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
LAVIOLLE, Bruno
FLUDROSEPSIS, NCT05001854: Hemodynamics Effects of Fludrocortisone on the Pressor Response to Noradrenaline Septic Shock Patients	Suspended	2/3	40	Europe	Fludrocortisone, Flucortac, Placebo	Rennes University Hospital, H.A.C. PHARMA	Septic Shock	06/24	12/24
LAINE, Fabrice
CESTO2, NCT04571216: Study Assessing Efficacy and Safety of NFL-101 as a Tobacco Cessation Therapy	Recruiting	2	318	Europe	NFL-101 dose 1, Tobacco leaf extract, NFL-101 dose 2, Placebo, WFI	NFL Biosciences SAS	Smoking Cessation, Nicotine Dependence	07/24	12/24
RESPIVAC, NCT05582239: Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults	Recruiting	N/A	2400	Europe		ANRS, Emerging Infectious Diseases, P95, I-REIVAC, EPICONCEPT, Institut de Recherche en Santé Publique, France	Severe Acute Respiratory Infection (SARI), Influenza, COVID-19	01/26	01/26